• Thumbnail for Pfizer–BioNTech COVID-19 vaccine
    version of the bivalent vaccine (Comirnaty Original/Omicron BA.1 or tozinameran/riltozinameran) was authorized as a booster for use in the UK. The same...
    236 KB (19,394 words) - 05:58, 20 April 2024
  • Thumbnail for N1-Methylpseudouridine
    in vitro transcription and is found in the SARS-CoV-2 mRNA vaccines tozinameran (Pfizer–BioNTech) and elasomeran (Moderna). N1-Methylpseudouridine is...
    16 KB (1,510 words) - 19:37, 11 April 2024
  • Thumbnail for Proprietary drug
    Pharma Proprietary medications Pfizer Generic Viagra, Comirnaty (tozinameran, co-op with BioNTech) GlaxoSmithKline Amoxil (amoxicillin), Ventolin (salbutamol)...
    33 KB (3,259 words) - 10:15, 7 April 2024
  • selexipag (2015), latanoprostene bunod (2017), benzhydrocodone (2018), tozinameran (2020) and serdexmethylphenidate (2021). Prodrugs can be classified into...
    12 KB (1,279 words) - 13:32, 23 February 2024
  • mRNA vaccine (0.05 mg per dose) that contains the active ingredient tozinameran. Pfizer–BioNTech COVID-19 vaccine nanoparticle ingredients ALC-0315 1...
    2 KB (205 words) - 21:16, 8 February 2024
  • (e.g. alipogene tiparvovec) -meran for messenger RNA products (e.g. tozinameran) The term stem is not used consistently in linguistics. It has been defined...
    17 KB (1,618 words) - 09:49, 26 November 2023
  • Administration (FDA) for the mRNA vaccine BNT162b2 (active ingredient tozinameran) on 20 November 2020. On 2 December 2020, the United Kingdom's Medicines...
    192 KB (21,930 words) - 19:29, 15 April 2024
  • the European Medicines Agency (EMA), and the first COVID-19 vaccine, Tozinameran from Pfizer/BioNTech, was approved on 21 December 2020. In concert with...
    6 KB (389 words) - 21:24, 27 August 2023
  • drugs. After October 2020, the company produced the COVID-19 vaccine tozinameran at the Brenna site on behalf of Biontech. Since the end of April 2021...
    4 KB (299 words) - 03:24, 28 March 2024
  • Thumbnail for History of COVID-19 vaccine development
    Administration (FDA) for the mRNA vaccine BNT162b2 (active ingredient tozinameran) on 20 November 2020. On 2 December 2020, the United Kingdom's Medicines...
    122 KB (11,028 words) - 02:32, 27 January 2024